Skip to main content
SpringerLink
Log in

Comorbidities Often Associated with Brain Damage in Hypertension: Dyslipidaemia

  • Chapter
  • First Online:
Hypertension and Brain Damage

Part of the book series: Updates in Hypertension and Cardiovascular Protection ((UHCP))

  • 1259 Accesses

Abstract

Brain function is directly and indirectly associated with lipoprotein levels and function. Thus, overproduction or deficiency of lipids and/or lipoproteins can significantly affect brain homeostasis. Although the development and progression of atheroma plaques represents probably the most recognized mechanism of stroke, dyslipidaemia can induce or aggravate stroke also through other mechanisms. In this chapter, we discuss how dyslipidaemia can affect the brain through several different pathways leading to brain deterioration and damage and how treatment with statins and cholesterol reduction may improve stroke outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D; ESC Committee for Practice Guidelines (CPG) 2008–2010 and 2010–2012 Committees (2011) ESC/EAS guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 32(14):1769–1818

    Google Scholar 

  2. Gotthardt M, Trommsdorff M, Nevitt MF, Shelton J, Richardson JA, Stockinger W, Nimpf J, Herz J (2000) Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction. J Biol Chem 275:25616–25624

    Article  CAS  PubMed  Google Scholar 

  3. Björkhem I, Meaney S (2004) Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol 24(5):806–815

    Article  PubMed  Google Scholar 

  4. Burger D, Dayer JM (2002) High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation? Autoimmun Rev 1:111–117

    Article  CAS  PubMed  Google Scholar 

  5. Ferretti G, Bacchetti T, Principi F, Di Ludovico F, Viti B, Angeleri VA, Danni M, Provinciali L (2005) Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity. Mult Scler 11:677–682

    Article  CAS  PubMed  Google Scholar 

  6. Jamroz-Wisniewska A, Beltowski J, Stelmasiak Z, Bartosik-Psujek H (2009) Paraoxonase 1 activity in different types of multiple sclerosis. Mult Scler 15:399–402

    Article  CAS  PubMed  Google Scholar 

  7. Zechariah A, ElAli A, Hagemann N, Jin F, Doeppner TR, Helfrich I, Mies G, Hermann DM (2013) Hyperlipidemia attenuates vascular endothelial growth factor-induced angiogenesis, impairs cerebral blood flow, and disturbs stroke recovery via decreased pericyte coverage of brain endothelial cells. Arterioscler Thromb Vasc Biol 33(7):1561–1567

    Article  CAS  PubMed  Google Scholar 

  8. Weinstock-Guttman B, Zivadinov R, Mahfooz N, Carl E, Drake A, Schneider J, Teter B, Hussein S, Mehta B, Weiskopf M, Durfee J, Bergsland N, Ramanathan M (2011) Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. J Neuroinflammation 8:127

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Fernández JA, Rojo L, Kuljis RO, Maccioni RB (2008) The damage signals hypothesis of Alzheimer's disease pathogenesis. J Alzheimers Dis 14(3):329–333

    PubMed  Google Scholar 

  10. Sparks DL, Scheff SW, Hunsaker JC 3rd, Liu H, Landers T, Gross DR (1994) Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol 126:88–94

    Article  CAS  PubMed  Google Scholar 

  11. Bodovitz S, Klein WL (1996) Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. J Biol Chem 271:4436–4440

    Article  CAS  PubMed  Google Scholar 

  12. Frears ER, Stephens DJ, Walters CE, Davies H, Austen BM (1999) The role of cholesterol in the biosynthesis of beta-amyloid. Neuroreport 10:1699–1705

    Article  CAS  PubMed  Google Scholar 

  13. Winkler EA, Bell RD, Zlokovic BV (2011) Central nervous system pericytes in health and disease. Nat Neurosci 14:1398–1405

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Choy PC, Siow YL, Mymin D, O K (2004) Lipids and atherosclerosis. Biochem Cell Biol 82(1):212–224

    Article  CAS  PubMed  Google Scholar 

  15. Oorni K, Pentikainen MO, Ala-Korpela M, Kovanen ET (2000) Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions. J Lipid Res 41:1703–1714

    CAS  PubMed  Google Scholar 

  16. Fei H, Berliner JA, Parhami F, Drake TA (1993) Regulation of endothelial tissue factor expression by minimally oxidized LDL and lipopolysaccharide. Arterioscler Thromb 13:1711–1717

    Article  CAS  PubMed  Google Scholar 

  17. Brand L, Banka CL, Madmann N, Terkeltaub RA, Fan ST, Curtiss LK (1994) Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes. Arterioscler Thromb 14:790–797

    Article  CAS  PubMed  Google Scholar 

  18. Latron Y, Chautan M, Anfosso F, Alessi MC, Nalbone G, Lafont H, Juhan-Vague I (1991) Stimulating effect of oxidized low density lipoproteins on plasminogen activator inhibitor-1 synthesis by endothelial cells. Arterioscler Thromb 11:1821–1829

    Article  CAS  PubMed  Google Scholar 

  19. Yang X, Cai B, Sciacca RR, Cannon PJ (1994) Inhibition of inducible nitric oxide synthase in macrophages by oxidized low-density lipoproteins. Circ Res 74:318–328

    Article  CAS  PubMed  Google Scholar 

  20. Bentzon JF, Otsuka F, Virmani R, Falk E (2014) Mechanisms of plaque formation and rupture. Circ Res 114(12):1852–1866

    Article  CAS  PubMed  Google Scholar 

  21. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW, Eddleman KM, Jarrett NM, LaBresh K, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2014) 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129(25 Suppl 2):S1–S45

    Google Scholar 

  22. Cholesterol Treatment Trialists’ (CTT) Collaboration (2010) Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170000 participants in 26 randomised trials. Lancet 376:1670–1681

    Article  Google Scholar 

  23. Ayata C, Shin HK, Dileköz E, Atochin DN, Kashiwagi S, Eikermann-Haerter K, Huang PL (2013) Hyperlipidemia disrupts cerebrovascular reflexes and worsens ischemic perfusion defect. J Cereb Blood Flow Metab 33(6):954–962

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. ElAli A, Doeppner TR, Zechariah A, Hermann DM (2011) Increased blood-brain barrier permeability and brain edema after focal cerebral ischemia induced by hyperlipidemia: role of lipid peroxidation and calpain-1/2, matrix metalloproteinase-2/9, and RhoA overactivation. Stroke 42(11):3238–3244

    Article  CAS  PubMed  Google Scholar 

  25. Hebert PR, Gaziano JM, Chan KS, Hennekens CH (1997) Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. JAMA 278(4):313–321

    Article  CAS  PubMed  Google Scholar 

  26. Bernick C, Katz R, Smith NI et al (2005) Statins and cognitive function in the elderly—the Cardiovascular Health Study. Neurology 65:1388–1394

    Article  CAS  PubMed  Google Scholar 

  27. Plehn JF, Davis BR, Sacks FM et al (1999) Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation 99(2):216–223

    Article  CAS  PubMed  Google Scholar 

  28. White HD, Simes RJ, Anderson NE et al (2000) Pravastatin therapy and the risk of stroke. N Engl J Med 343(5):317–326

    Article  CAS  PubMed  Google Scholar 

  29. Flint AC, Kamel H, Navi BB et al (2012) Statin use during ischemic stroke hospitalization is strongly associated with improved poststroke survival. Stroke 43(1):147–154

    Article  CAS  PubMed  Google Scholar 

  30. Ní Chróinín D, Asplund K, Åsberg S et al (2013) Statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and randomized trials. Stroke 44(2):448–456

    Article  PubMed  Google Scholar 

  31. Sillesen H, Amarenco P, Hennerici MG, et al. Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators (2008) Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 39(12):3297–3302

    Google Scholar 

  32. Ní Chróinín D, Callaly EL, Duggan J et al (2011) Association between acute statin therapy, survival, and improved functional outcome after ischemic stroke: the North Dublin Population Stroke Study. Stroke 42(4):1021–1029

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Intermedica Clinic for Internal Disease, Hypertension Center, Jovana Ristica 20/2, Nis, 1800, Serbia

    Dragan Lovic FESC, FACP

  2. Cardiology Department, Hypertension Centre, Asklepeion General Hospital, Athens, Greece

    Manolis S. Kallistratos & Athanasios J. Manolis

Authors
  1. Dragan Lovic FESC, FACP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manolis S. Kallistratos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Athanasios J. Manolis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dragan Lovic FESC, FACP .

Editor information

Editors and Affiliations

  1. Hypertension & Vascular Risk Unit, Hospital Clínic, Barcelona, Spain

    Antonio Coca

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Lovic, D., Kallistratos, M.S., Manolis, A.J. (2016). Comorbidities Often Associated with Brain Damage in Hypertension: Dyslipidaemia. In: Coca, A. (eds) Hypertension and Brain Damage. Updates in Hypertension and Cardiovascular Protection. Springer, Cham. https://doi.org/10.1007/978-3-319-32074-8_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-32074-8_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-32072-4

  • Online ISBN: 978-3-319-32074-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation